URN:NBN:SI:doc-XZNWW5AP2022Knez, LeaKrivec, EvaŠamec, NejaZottel, Aljadocuments/doc/X/URN_NBN_SI_doc-XZNWW5AP_001.pdfdocuments/doc/X/URN_NBN_SI_doc-XZNWW5AP_001.txt173articlestr. 13-220014-8229104190211URN:NBN:SI:doc-XZNWW5APslvSlovensko farmacevtsko društvoFarmacevtski vestnikInCCAR-Tglioblastomglioblastomaimmunotherapyimunoterapijahow far (yet) to clinical use?Immunotherapy in the treatment of glioblastomaImunoterapija pri zdravljenju glioblastomakako daleč (še) do klinične uporabe?